Our Publications
2025 American Academy of Neurology Annual Meeting
Iodice V, et al. | Program Number S9.001
NET-Inhibition with Ampreloxetine, Blood Pressure, and Catecholamines in Patients with Neurogenic Orthostatic Hypotension
Norcliffe-Kaufmann L, et al. | Program Number S9.002
The Impact of Ampreloxetine on Supine Hypertension: An Ambulatory Blood Pressure Monitoring Study
2023 American Autonomic Society’s International Symposium
Kaufmann H, et al. | Poster #95
Evaluating clinically meaningful changes in the OHSA domain of the OHQ
2022 American Autonomic Society’s International Symposium
Biaggioni I, et al. Abstract 34 | Virtual Poster 106
A phase 3, 22-week, multi-center, randomized withdrawal study of ampreloxetine in treating symptomatic nOH
Kaufmann H, et al. Abstract 33 | Virtual Poster 117
Blood pressure and pharmacodynamic response of ampreloxetine, a norepinephrine reuptake inhibitor, in patients with symptomatic nOH
Freeman R, et al. Abstract 30 | Virtual Poster 4
Longitudinal analysis of ampreloxetine for the treatment of symptomatic nOH in subset of patients with MSA